BIOPORTO DIAGNOSTICS
BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Their pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. They sell their products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.
BIOPORTO DIAGNOSTICS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Address:
Denmark, South Carolina, United States
Country:
United States
Website Url:
http://www.bioporto.com
Total Employee:
11+
Status:
Active
Contact:
+45 45 29 00 00
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache
Similar Organizations
BioMark Diagnostics
BioMark Diagnostics is an oncology-focused company.
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.bioporto.com Semrush global rank: 3.65 M Semrush visits lastest month: 3.88 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioPorto Diagnostics"
About BioPorto - Bioporto
Apr 12, 2024 BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes …See details»
About BioPorto - BioPorto US
Oct 22, 2024 Serving as BioPorto’s General Counsel since 2011, Gry leads the Company’s legal activities including compliance, fundraising, IPR, contracts, HR and ESG. From 2019 to 2024, …See details»
BioPorto A/S Announces Changes to the US Commercial …
October 21, 2024 News release. BioPorto A/S Announces Changes to the US Commercial Organization. COPENHAGEN, DENMARK and BOSTON, MA, USA, October 21, 2024, …See details»
BioPorto A/S - LinkedIn
BioPorto is excited to announce that Dr. Andrew Allegretti will be the Principal Investigator, and ProPharma has been selected as the Clinical Research Organization for its upcoming initial US ...See details»
BioPorto A/S Announces Changes to the US Commercial
October 21, 2024 News release. BioPorto A/S Announces Changes to the US Commercial Organization. COPENHAGEN, DENMARK and BOSTON, MA, USA, October 21, 2024, …See details»
BioPorto Diagnostics - Crunchbase Company Profile & Funding
BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. …See details»
Investor Relations - Bioporto
Jan 2, 2025 BioPorto aims to provide its investors with open, satisfactory information about the company’s operations, strategy and results.See details»
BioPorto A/S Appoints President and CEO of BioPorto Inc.
May 7, 2024News release BioPorto A/S Appoints President and CEO of BioPorto Inc. COPENHAGEN, DENMARK and BOSTON, MA, USA, May 7, 2024, (GLOBE NEWSWIRE)...See details»
BioPorto A/S Announces Changes to the US Commercial …
October 21, 2024 News release BioPorto A/S Announces Changes to the US Commercial Organization COPENHAGEN, DENMARK and BOSTON, MA, USA, October 21, 2024, …See details»
Distributor Opportunities - Bioporto
Jul 10, 2023 We are looking for distribution partners to bring The NGAL Testâ„¢ into clinical laboratories and present NGAL benefits to clinicians. We are also looking for partners for our …See details»
BioPorto - Products, Competitors, Financials, Employees, …
BioPorto is an IN-vitro diagnostics company specializing in biomarker assays for the healthcare sector. Use the CB Insights Platform to explore BioPorto's full profile. ... 2024 Expansion of …See details»
BioPorto A/S Announces Changes to the US Commercial …
Oct 21, 2024 Tim Eriksen, +45 4529 0000, [email protected]. Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577, [email protected]. About BioPorto. BioPorto is an in vitro …See details»
BioPorto Diagnostics - Craft
Sep 30, 2024 BioPorto Diagnostics is an in-vitro diagnostic company that provides biomarkers, research antibodies, and assays to scientists and clinicians. Its main product is a neutrophil …See details»
BioPorto A/S Announces Changes to the US Commercial …
Oct 21, 2024 COPENHAGEN, DENMARK and BOSTON, MA, USA, October 21, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics …See details»
BioPorto A/S | Globenewswire - via.ritzau.dk
4 days ago BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes …See details»
Annual Reports - Bioporto
Apr 4, 2024 Annual Reports 2023 Annual Report Annual Report [EN] Annual Report – XHTML [EN] Remuneration Report [EN] 2022 Annual Report Annual Report [EN] Annual Report ...See details»
BioPorto A/S publishes prospectus in connection with a
Mar 7, 2022 BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes …See details»
Careers - BioPorto US
Dec 16, 2024 BioPorto is an agile, mission-driven company focused on launching novel biomarker tests designed to help improve patient outcomes. Project Manager Enthusiastic and …See details»
Announcements - Bioporto
Nov 14, 2024 BioPorto A/S. BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 . Thu, 14 Nov 2024 07:50 GMT. BioPorto A/S. …See details»
Investor Presentations - Bioporto
Aug 15, 2024 BioPorto investor presentations and virtual meetings. Learn more about the company, highlights, accomplishments and strategic goals.See details»